Clayton Pharmaceuticals

Clayton Pharmaceuticals is a biopharmaceutical company focused on strategic collaborations with other pharmaceutical companies to accelerate the development and regulatory approval of generic (ANDA), specialty (505(b)(2)), and novel drug products that present significant market entry challenges. The company's mission is to continuously develop innovative research tools that can be used to establish bioequivalence for complex marketed products, thereby increasing patient access.